Morbimortality in COVID-19 positive patients
DOI:
https://doi.org/10.35381/s.v.v6i1.1723Keywords:
Indicators of morbidity and mortality, global burden of disease, statistics & numerical data. (Source, DeCS).Abstract
Objective: Description of the current morbimortality of COVID-19 positive patients at the Hospital General Docente "Ambato", in order to understand the behavior of the virus. Method: Descriptive observational and case analysis of patient morbimortality. Results: the highest prevalence of COVID-19 cases is found in mature adults (40-65 years) with 48.1% of registered cases. Conclusion: The pathogenesis in COVID-19 patients; in the records provided by the Hospital General Docente Ambato, it is evident that the existence of some comorbidity of chronic course, especially in cardiovascular, respiratory, renal and endocrine-metabolic pathologies; adding to this, in the most vulnerable populations such as mature adults (40 - 64 years of age); older adults (> 65 years of age); would explain the high mortality rate and the implications of the appearance of critical cases, due to the severity of the evolutionary complications leading to a fatal outcome in human life.
Downloads
References
Ministerio de Salud Pública de la República del Ecuador. Coronavirus COVID 19 [Coronavirus COVID 19]. [Internet]. 2021. Disponible en: https://www.salud.gob.ec/actualizacion-de-casos-de-coronavirus-en-ecuador/
Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020 Jun 5;12(11):10087-10098. doi: 10.18632/aging.103415. PMID: 32501810; PMCID: PMC7346072.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450-452. doi: 10.1038/s41591-020-0820-9. PMID: 32284615; PMCID: PMC7095063.
Alshahawey M, Raslan M, Sabri N. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Curr Res Transl Med. 2020 Nov;68(4):149-150. doi: 10.1016/j.retram.2020.08.002. Epub 2020 Sep 6. PMID: 32917573; PMCID: PMC7474911.
Castelli F. SARS-CoV-2 pandemic in the western world: the lessons learned. J R Coll Physicians Edinb. 2020;50(2):110-111. doi: 10.4997/JRCPE.2020.205. PMID: 32568277.
Graham RL, Baric RS. SARS-CoV-2: Combating Coronavirus Emergence. Immunity. 2020;52(5):734-736. doi: 10.1016/j.immuni.2020.04.016. Epub 2020 May 8. PMID: 32392464; PMCID: PMC7207110.
Bernal-Sprekelsen M, Avilés-Jurado FX, Álvarez Escudero J, et al. Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection. Acta Otorrinolaringol Esp (Engl Ed). 2020;71(6):386-392. doi:10.1016/j.otorri.2020.04.002
Villalonga Vadell R, Martín Delgado MC, Avilés-Jurado FX, et al. Consensus Document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on Tracheotomy in Patients with COVID-19 Infection. Rev Esp Anestesiol Reanim (Engl Ed). 2020;67(9):504-510. doi:10.1016/j.redar.2020.05.001
Serra M.A. COVID-19. De la patogenia a la elevada mortalidad en el adulto mayor y con comorbilidades [COVID-19. From pathogenesis to high mortality in the older adult with comorbidities]. Rev haban cienc méd [Internet]. 2020; 19(3): 3379.
Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-1839. doi:10.1016/j.jiph.2020.07.014
Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228):e52. doi:10.1016/S0140-6736(20)30558-4
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345-357. doi:10.1080/14787210.2020.1822737
Urizarri P, Rodríguez R, Almaguer M. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis [Comorbidities and clinical severity of COVID-19: systematic review and meta-analysis.]. Rev haban cienc méd [Internet]. 2020 [Citado 11/03/21]; 19: e3389. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3389
Dioh W, Chabane M, Tourette C, et al. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):42. doi:10.1186/s13063-020-04998-5
Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):897. doi:10.1186/s13063-020-04819-9
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
